The European Society of Cardiology ESC recommends that all individuals over the age of 65 should be screened opportunistically for atrial fibrillation, and those over the age of 75 should be screened systematically. With Awario, screening can be carried out effortlessly and cost-effectively. With reliable analytics and an easy-to-use interface, the physician can save work time by easily monitoring the patient’s heart rhythm and focusing only on ECG recordings where findings occur.